Skip to main content
. 2024 Mar 28;19(3):333–342. doi: 10.1007/s11523-024-01051-2
A novel therapy using a nanocell to deliver chemotherapy directly to the tumour is well tolerated in paediatric patients.
In this study one in three patients with relapsed or refractory brain tumour or solid tumours showed expression of the epidermal growth factor receptor, which can potentially be used as a therapeutic target.